Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | IL-17A Antagonist for PsO, PsA, & AS - COSENTYX (secukinumab) |
Description | Learn about COSENTYX (secukinumab), the first fully human monoclonal antibody to selectively target IL-17A approved for plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. |
Keywords | N/A |
WebSite | www.cosentyxhcp.com |
Host IP | 194.209.178.12 |
Location | Hittnau / Hittnau (Dorf), Zurich, Switzerland |
Site | Rank |
cosentyx.com | #213,438 |
hcpfirst.com | #4,853,320 |
ankylosingspondylitisnews.com | #1,431,581 |
novartispharma.com | #2,523,870 |
psoriasisclub.org | #9,891,445 |
cosmeticsandskin.com |
costacruises.co.uk |
cp2y.com |
craftroots.org |
creativedo.co |
crisilinfotech.com |
cryptofarm.uk |
cs-cart.eu.com |
ctcis.net |
ctis.edu.bd |
k-international.com |
k9ofmine.com |
US$2,666
Last updated: Dec 14, 2019
Cosentyxhcp.com has global traffic rank of 6,337,240. Cosentyxhcp.com has an estimated worth of US$ 2,666, based on its estimated Ads revenue. Cosentyxhcp.com receives approximately 486 unique visitors each day. Its web server is located in Hittnau / Hittnau (Dorf), Zurich, Switzerland, with IP address 194.209.178.12. According to SiteAdvisor, cosentyxhcp.com is safe to visit. |
Purchase/Sale Value | US$2,666 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$43 |
Yearly Ads Revenue | US$533 |
Daily Unique Visitors | 486 |
Note: All traffic and earnings values are estimates. |
Global Rank | 6,337,240 |
Delta (90 Days) | 0 |
Most Popular In Country | N/A |
Country Rank | N/A |
Host | Type | TTL | Data |
cosentyxhcp.com | A | 21599 | IP: 194.209.178.12 |
cosentyxhcp.com | NS | 21599 | Target: dns1.novartis.com. |
cosentyxhcp.com | NS | 21599 | Target: dns2.novartis.com. |
cosentyxhcp.com | NS | 21599 | Target: dns4.novartis.com. |
cosentyxhcp.com | NS | 21599 | Target: dns3.novartis.com. |
cosentyxhcp.com | TXT | 21599 | TXT: be8d47f6-e31c-477c-a11c-5d81488feea5 |
cosentyxhcp.com | SOA | 21599 | MNAME: dns1.novartis.com. RNAME: hostmaster.novartis.com. Serial: 2019082601 Refresh: 86400 Retry: 3600 Expire: 2592000 Minimum TTL: 172800 |
HTTP/1.1 302 Found Date: Sat, 14 Dec 2019 23:43:24 GMT X-Frame-Options: DENY X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Content-Type: text/html; charset=iso-8859-1 Location: http://www.cosentyxhcp.com/ Vary: Accept-Encoding Content-Length: 211 HTTP/1.1 301 Moved Permanently Date: Sat, 14 Dec 2019 23:43:26 GMT Cache-Control: no-cache,must-revalidate,max-age=0,no-store,private Expires: Thu, 01 Jan 1970 00:00:00 GMT Location: https://www.cosentyxhcp.com/ Transfer-Encoding: chunked HTTP/1.1 200 OK Date: Sat, 14 Dec 2019 23:43:26 GMT Cache-Control: public,must-revalidate,max-age=0,s-maxage=600 X-Powered-By: Salesforce.com ApexPages P3P: CP="CUR OTR STA" Expires: Sat, 14 Dec 2019 23:43:27 GMT Last-Modified: Sat, 14 Dec 2019 23:43:27 GMT Content-Type: text/html; charset=UTF-8 Transfer-Encoding: chunked |
Domain Name: COSENTYXHCP.COM Registry Domain ID: 1930020080_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2019-06-20T17:58:02Z Creation Date: 2015-05-18T14:25:22Z Registry Expiry Date: 2021-05-18T14:25:22Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ Domain Name: cosentyxhcp.com Registry Domain ID: 1930020080_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2019-12-14T00:10:01-0800 Creation Date: 2015-05-18T07:25:22-0700 Registrar Registration Expiration Date: 2021-05-18T00:00:00-0700 Registrar: MarkMonitor, Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited) Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited) Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited) Registry Registrant ID: Registrant Name: Domain Admin Registrant Organization: Novartis AG Registrant Street: P.O. Box CH-4002, Registrant City: Basel Registrant State/Province: CH Registrant Postal Code: 4002 Registrant Country: CH Registrant Phone: +1.2083895740 Registrant Phone Ext: Registrant Fax: +1.2083895799 Registrant Fax Ext: Registrant Email: novartis.domains@markmonitor.com Admin Organization: MarkMonitor, Inc. Admin State/Province: ID Admin Country: US Tech Organization: MarkMonitor, Inc. Tech State/Province: ID Tech Country: US Name Server: dns1.novartis.com Name Server: dns2.novartis.com Name Server: dns3.novartis.com Name Server: dns4.novartis.com DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ MarkMonitor is the Global Leader in Online Brand Protection. MarkMonitor Domain Management(TM) MarkMonitor Brand Protection(TM) MarkMonitor AntiCounterfeiting(TM) MarkMonitor AntiPiracy(TM) MarkMonitor AntiFraud(TM) Professional and Managed Services Visit MarkMonitor at https://www.markmonitor.com Contact us at +1.8007459229 In Europe, at +44.02032062220 |